SpliSense Revenue and Competitors

Jerusalem, il

Location

$43M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SpliSense's total funding is $43M.

Employee Data

  • SpliSense has 15 Employees.(i)
  • SpliSense grew their employee count by -6% last year.

SpliSense's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CSO and Scientific FounderReveal Email/Phone
3
CEOReveal Email/Phone
4
VP CMCReveal Email/Phone
5
VP, ResearchReveal Email/Phone
6
Director Clinical and Regulatory AffairsReveal Email/Phone
7
Senior ResearcherReveal Email/Phone
8
CBOReveal Email/Phone
9
Research AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2353%N/AN/A
#2
N/A4940%$22MN/A
#3
N/A327%$23.4MN/A
#4
N/A15-6%$43MN/A
#5
N/A4326%$12.5MN/A
#6
N/A280%N/AN/A
#7
N/A249%$16.1MN/A
#8
N/A80%N/AN/A
#9
N/A196%$8.44MN/A
#10
N/A40%N/AN/A
Add Company

What Is SpliSense?

SpliSense Ltd., is a growing and exciting biotechnology company, developing novel therapies for genetic diseases by inhalation. The company is currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients.

keywords:N/A

$43M

Total Funding

15

Number of Employees

N/A

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M15-32%N/A
#2
N/A15N/AN/A
#3
$4.2M150%$12M
#4
$4.9M15-25%N/A
#5
$5.3M170%N/A